V026-1213 Screening compound: 3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide

V026-1213 Screening compound: 3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide
V026-1213 Screening compound: 3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V026-1213
3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V026-1213

Molecular Formula

C26H29ClN4O4S (C26 H29 ClN4 O4 S)

Compound Name

3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]propanamide

IUPAC name

3-[2-(4-chlorophenoxy)-N-cyclohexylacetamido]-N-[5-(3-methoxyphenyl)-134-thiadiazol-2-yl]propanamide

SMILES

COc1cccc(-c2nnc(NC(CCN(C3CCCCC3)C(COc(cc3)ccc3Cl)=O)=O)s2)c1

InChI

InChI=1S/C26H29ClN4O4S/c1-34-22-9-5-6-18(16-22)25-29-30-26(36-25)28-23(32)14-15-31(20-7-3-2-4-8-20)24(33)17-35-21-12-10-19(27)11-13-21/h5-6,9-13,16,20H,2-4,7-8,14-15,17H2,1H3,(H,28,30,32)

InChI Key

FESWBMGZOOEDFO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19715030

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

529.06

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.636

Distribution Coefficient, logD

5.636

Water Solubility, LogSw

-5.98

Polar Surface Area

76.339

Acid Dissociation Constant (pKa)

10.55

Base Dissociation Constant (pKb)

5.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

V026-1213 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V026-1213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V026-1213?
Check Price and Availability of V026-1213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V026-1213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V026-1213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V026-1213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V026-1213 available by request